Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+36.6%
5Y CAGR+42.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+36.6%/yr
vs +51.9%/yr prior
5Y CAGR
+42.0%/yr
Recent deceleration
Acceleration
-15.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.8x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $332.06M | +38.3% |
| 2024 | $240.16M | +42.5% |
| 2023 | $168.53M | +29.4% |
| 2022 | $130.22M | +54.6% |
| 2021 | $84.25M | +46.3% |
| 2020 | $57.60M | +38.8% |
| 2019 | $41.51M | +69.6% |
| 2018 | $24.48M | +165.1% |
| 2017 | $9.23M | +81.0% |
| 2016 | $5.10M | - |